Cabozantinib Now Also FDA Approved for Liver Cancer Cabozantinib Now Also FDA Approved for Liver Cancer

A new indication allows cabozantinib to be used in patients with hepatocellular carcinoma who have previously been treated with sorafenib.FDA Approvals

Source: Medscape Hematology-Oncology Headlines - January 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news